Cingulate Inc. - Common Stock — 현금 흐름 (NASDAQ:CING)

Financials

영업활동으로 인한 현금 -10.43 M-15.88 M-15.03 M-18.45 M-17.25 M -19.55 M 투자 활동으로 인한 현금 -814.74 K-152.65 K-224.1 K-211.8 K-162.14 K -223.32 K 재무활동으로 인한 현금 26.54 M4.9 M9.95 M30.82 M16.15 M 36.15 M 잉여 현금 흐름 -11.25 M-15.88 M-15.03 M-18.45 M-17.41 M -19.77 M

뉴스

Cingulate, 주식 공모 한도 3,190만 달러로 증액

Cingulate increases at-the-market offering limit to $31.9 million

Cingulate, 셰인 샤퍼 CEO 복귀 및 고용 조건 변경 발표

Cingulate reinstates Shane Schaffer as CEO, updates employment terms

Cingulate appoints new CCO, secures $6 million financing

Cingulate’s ADHD drug meets primary endpoints in phase 3 trial

FDA, Cingulate ADHD 치료제 승인 검토, 2026년 5월 목표

FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date

Cingulate, ADHD 치료제 생산 계약 체결

Cingulate secures manufacturing deal with Bend Bio Sciences for ADHD drug

Cingulate issues shares to lender in series of unregistered transactions

Cingulate appoints John A. Roberts as executive chairman, CEO placed on leave